Table 4

Demographic and neuropsychological data from the subject groups

Test Controls Mean (SD) AD
Mean (SD)
Semantic dementia Mean (SD) FvFTD Mean (SD) ANOVA p Value
Male:female ratio10:819:119:812:1
Age (y)70.6 (5.7)70.4 (8.2)61.9 (6.3)58 (7.8)<0.00054-150
 Range60–8254–8351–7743–71
Duration of symptoms (y)NA4.7 (2.9)4.8 (2.7)4.5 (2.4)NS
 RangeNA1–92–102–10
Duration of follow up (y)NA3.6 (2.3)3.3 (2.4)2.6 (1.8)NS
 RangeNA1–81–81–8
MMSE (30)28 (0.97)22.2 (3.1)19.1 (7.8)25.6 (4.0)<0.00054-151
 Range27–3013–276–2917–30
CDRNA0.9 (0.7)0.9 (0.5)NTNS
 RangeNA0–20.5–2NT
Rey copy34.4 (1.5)29.4 (7.9)31.1 (4.6)32.9 (3.0)<0.034-152
Rey recall18.8 (5.5)3.8 (4.8)12.4 (8.4)17.1 (9.0)<0.00014-152
Naming (64)62.8 (0.9)58.8 (6.2)24.4 (26.4)61.3 (1.1)<0.00014-153
PPT words51.4 (0.9)49.8 (2.4)38.5 (8.5)48.5 (6.5)<0.00014-153
NPINT5.7 (9.6)16.0 (12.7)42.7 (13.6)<0.00014-154
  • 4-150 Semantic dementia and fvFTD groups significantly younger than controls and AD group on Tukey test (p<0.05).

  • 4-151 AD and semantic dementia groups both significantly worse than control and fvFTD groups on Tukey test (p<0.05).

  • 4-152 AD group significantly impaired compared with the other groups on Tukey test.

  • 4-153 Semantic dementia group significantly impaired compared with the other groups on Tukey test.

  • 4-154 FvFTD group significantly impaired compared with the other groups on Tukey test.

  • NT=not tested; NA=not applicable; AD=Alzheimer's disease; fvFTD=frontal variant frontotemporal dementia; MMSE= mini mental state examination41; CDR=clinical dementia rating35; PPT words=pyramids and palm trees test33; NPI=neuropsychiatric inventory34